Precigen gets FDA orphan drug status for PRGN-2012 in RRP

Precigen has secured orphan drug designation (ODD) for PRGN-2012 from the US Food and Drug Administration (FDA) in recurrent respiratory papillomatosis (RRP). PRGN-2012 is an ... Read More